The Health Services (Cross-Border Health Care) Regulations (Northern Ireland) 2013

Regulation 5A

[F1 SCHEDULE N.I. Elements that must be included in prescriptions intended to be used in another member State

Textual Amendments

F1 Sch. added (27.3.2015) by The Health Services (Cross-Border Health Care) (Amendment) Regulations (Northern Ireland) 2015 (S.R. 2015/130), regs. 1, 2(3)

1.   The patient’s— N.I.

(a) surname,

(b) first names, and

(c) date of birth.

2.   The issue date of the prescription. N.I.

3.   The prescribing professional’s— N.I.

(a) surname,

(b) first names,

(c) professional qualification,

(d) direct contact details including—

(i) email address, and

(ii) telephone or fax number with the appropriate international prefix,

(e) work address,

(f) member State in which the professional works,

(g) signature (either written in ink or electronic depending on the medium chosen for issuing the prescription).

4.   The details of the prescribed product, including where applicable the— N.I.

(a) common name as defined by Article 1 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (“Directive 2001/83/EC”),

(b) brand name if—

(i) the prescribed product is a biological medicinal product, as defined in point 3.2.1.1(b) of Annex 1 (Part 1) to Directive 2001/83/EC, or

(ii) the prescribing professional deems it medically necessary for that product to be dispensed and, in that case, the prescribing professional’s reasons justifying the use of the brand name,

(c) pharmaceutical formulation (such as tablet, solution etc),

(d) quantity,

(e) strength, as defined in Article 1 of Directive 2001/83/EC, and

(f) dosage regimen.]